Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy

Cancer Chemotherapy and Pharmacology

Volumn 57, Issue 1, 2006, Pages 40-45

  Bellnier, David A ^a   Greco, William R ^a   Nava, Hector ^a   Loewen, Gregory M ^a   Oseroff, Allan R ^a   Dougherty, Thomas J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

HPPH; Photochemotherapy; Photodynamic therapy; Photofrin; Phototoxicity; Solar simulator

Indexed keywords

PHEOPHORBIDE; PHOTOCHLOR; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CANCER; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INFUSION; DRUG RESPONSE; ERYTHEMA; FEMALE; HUMAN; LIGHT EXPOSURE; MALE; MEASUREMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTOXICITY; PRIORITY JOURNAL; SKIN EDEMA; SKIN MANIFESTATION; SKIN SENSITIVITY; SKIN TOXICITY; SOLAR RADIATION;

DIHEMATOPORPHYRIN ETHER; FEMALE; HUMANS; MALE; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY DISORDERS; PHOTOSENSITIZING AGENTS; SKIN; ULTRAVIOLET RAYS;

EID: 28244464849     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0015-6     Document Type: Article

References (19)

1. Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Pandey RK, Tsuchida T, Dougherty TJ (2003) Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Cancer Res 63:1806-1813
2. Bellnier DA, Dougherty TJ (1996) A preliminary pharmacokinetics study of intravenous Photofrin in patients. J Clin Laser Med Surg 14:311-314
3. Bellnier DA, Henderson BW, Pandey RK, Potter WR, Dougherty TJ (1993) Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a. J Photochem Photobiol B Biol 20:55-61
4. Berr F (2004) Photodynamic therapy for cholangiocarcinoma. Sem Liver Dis 24:177-187
5. Dougherty TJ, Levy JG (2003) Photodynamic therapy (PDT) and clinical applications Biomedical photonics handbook. CRC, Boca Raton
6. Dougherty TJ, Cooper MT, Mang TS (1990) Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg Med 10:485-488
7. Eljamel MS (2003) New light on the brain: the role of photosensitizing agents and laser light in the management of invasive intracranial tumors. Tech Cancer Res Treat 2:303-309
8. Fitzpatrick TB (1988) The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988 124:869-871
9. Friedberg JS, Mick R, Stevenson JP, Zhu T, Busch TM, Shin D, Smith D, Culligan M, Dimofte A, Glatstein E, Hahn SM (2004) Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J Clin Oncol 22:2192-2201
10. Kormeili T, Yamauchi PS, Lowe NJ (2004) Topical photodynamic therapy in clinical dermatology. Brit J Dermatol 150:1061-1069
11. Mlkvy P, Messman H, Regula J, Conio M, Pauer M, Millson CE, MacRobert AJ, Bown SG (1998) Photodynamic therapy for gastrointestinal tumors using three photosensitizers-ALA induced PPIX, Photofrin and MTHPC. A pilot study. Neoplasma 45:157-161
12. Moghissi K, Dixon K (2003) Photodynamic therapy (PDT) in esophageal cancer: a surgical view of its indications based on 14 years experience. Tech Cancer Res Treat 2:319-326
13. Moriwaki S-I, Misawa J, Yoshinari Y, Yamada I, Takigawa M, Tokura Y (2001) Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin). Photodermatol Photoimmunol Photomed 17:241-243
14. Pandey RK (2004) Synthetic strategies in designing porphyrin-based photosensitizers for photodynamic therapy. CRC handbook of organic photochemistry and photobiology. CRC, Boca Raton
15. Vogl TJ, Eichler K, Mack MG, Zangos S, Herzog C, Thalhammer A, Engelmann K (2004) Interstitial photodynamic laser therapy in interventional oncology. Eur Radiol 14:1063-1073
16. Wagnieres G, Hadjur C, Grosjean P, Braichotte D, Savary J-F, Monnier P, van den Bergh H (1998) Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin. Photochem Photobiol 68:382-387
17. Weishaupt KR, Gomer CJ, Dougherty TJ (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 36:2326-2329
18. Wolfsen HC, Woodward TA, Raimondo M (2002) Photodynamic therapy for dysplatic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 77:1176-1181
19. Wooten RS, Smith KC, Ahlquist DA, Muller SA, Balm RK (1988) Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative. Lasers Surg Med 8:294-300